Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Israel

European Innovation Council · Running

V-sling Transcatheter Ventricular Repair Device for treatment of Heart Failure Patients

Coordinator
Cardiac Success Ltd, Israel
Runs
1 May 2022 to 30 April 2026
Status
Running
EU funding
€2.5m
Total cost
€8.5m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190122502

What the project is doing

In the project's own words, from its summary on CORDIS.

Heart failure (HF) represents a major public health concern, affecting around 13M people worldwide. A major risk factor for HF is a myocardial infarction, which causes ventricular remodelling, during which the ventricle enlarges, making the heart even less effective at pumping blood, and results in displacement of the papillary muscle. Progressive papillary muscle displacement leads to severe Functional Mitral Regurgitation in about 20% of the patients, the only ones currently receiving treatment because of the severity of the condition.

The remaining 80% of patients don’t experience severe FMR and are not considered for surgery: they will continue to suffer, and likely die since there is no therapeutic option available. Cardiac Success develops the V-sling system, a transcatheter ventricular repair device to improve cardiac function in HF patients. The objectives of the project are to finalize product optimization, complete V&V and pre-clinical testing, and perform the FIH study.

Topics

Who is involved

OrganisationCityCountryRole
Cardiac Success LtdYokneam IllitIsraelCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI